Desmopressin
Also known as: DDAVP, Minirin, 1-deamino-8-D-arginine vasopressin
Desmopressin is a synthetic analog of vasopressin (antidiuretic hormone) that increases water reabsorption in the kidneys and enhances blood clotting by releasing factor VIII and von Willebrand factor. This peptide hormone analog demonstrates significantly longer duration of action than natural vasopressin due to structural modifications that prevent enzymatic breakdown.
Desmopressin is a 1069.2 g/mol research peptide. Desmopressin is a synthetic analog of vasopressin (antidiuretic hormone) that increases water reabsorption in the kidneys and enhances blood clotting by releasing factor VIII and von Willebrand factor. This peptide hormone analog demonstrates significantly longer duration of action than natural vasopressin due to structural modifications that prevent enzymatic breakdown.
Also called: DDAVP, Minirin, 1-deamino-8-D-arginine vasopressin
1069.2 g/mol
Molecular Weight
Daltons
3
Strong Evidence
benefits
4
Studies Cited
peer-reviewed
10-40
Typical Dose
mcg
Overview
Desmopressin represents a breakthrough in vasopressin replacement therapy, engineered with specific amino acid modifications that extend its biological activity. The peptide works by binding to V2 receptors in the kidney's collecting duct, triggering insertion of aquaporin-2 water channels that dramatically increase water reabsorption. Beyond its antidiuretic effects, desmopressin stimulates release of stored factor VIII and von Willebrand factor from endothelial cells, making it valuable for certain bleeding disorders. The synthetic nature eliminates the vasoconstrictive effects seen with natural vasopressin, providing targeted therapeutic action without cardiovascular complications.
Key Takeaways: Desmopressin
- Strongest evidence supports Desmopressin for diabetes insipidus management and hemophilia a and von willebrand disease
- Research doses typically range from 10 to 40 mcg via intranasal
- 3 benefits with strong evidence, 3 moderate, 0 preliminary
- Half-life: 1.5-2.5 hours (nasal), 3.5 hours (subcutaneous)
- 4 cited research studies in this guide
Mechanism of Action
Desmopressin selectively binds to V2 receptors in renal collecting duct cells, activating adenylyl cyclase and increasing cAMP levels. This cascade promotes insertion of aquaporin-2 water channels into the apical membrane, enhancing water reabsorption. Simultaneously, desmopressin triggers release of factor VIII and von Willebrand factor from Weibel-Palade bodies in endothelial cells through V2 receptor activation, improving hemostatic function.
Research Benefits
Desmopressin at a Glance
Desmopressin selectively binds to V2 receptors in renal collecting duct cells, activating adenylyl cyclase and increasing cAMP levels.
Diabetes Insipidus Management
Strong EvidenceEffectively replaces deficient ADH in central diabetes insipidus, reducing urine output from 10-15 liters to normal levels by restoring kidney water reabsorption capacity.
Hemophilia A and von Willebrand Disease
Strong EvidenceIncreases factor VIII levels 3-5 fold and von Willebrand factor by 2-4 fold, providing hemostatic support for mild to moderate bleeding disorders without blood product exposure.
Nocturnal Enuresis Control
Strong EvidenceReduces nighttime urine production in children and adults with primary nocturnal enuresis, achieving dry nights in 60-70% of patients through enhanced overnight antidiuresis.
Perioperative Bleeding Reduction
Moderate EvidenceDecreases surgical blood loss by 20-40% in procedures involving patients with mild bleeding disorders or those requiring enhanced hemostasis.
Nocturia Treatment
Moderate EvidenceReduces nighttime urination frequency in adults with nocturnal polyuria, improving sleep quality and reducing falls in elderly populations.
Platelet Function Enhancement
Moderate EvidenceImproves platelet aggregation and adhesion through increased von Willebrand factor availability, particularly beneficial in uremic bleeding and certain platelet disorders.
Research Dosing Protocols
Research Purposes Only: All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
| Research Protocol | Dose Range | Route |
|---|---|---|
| Central diabetes insipidus | 10–40 mcg | intranasal |
| Hemophilia A/vWD | 0.3–0.4 mcg/kg | subcutaneous |
| Nocturnal enuresis | 20–40 mcg | intranasal |
| Nocturia | 25–100 mcg | sublingual |
Frequency
1-3 times daily depending on indication
Timing
Morning and evening for diabetes insipidus; bedtime for enuresis
Cycle Length
Continuous therapy with periodic assessment
Research Notes
- 1Start with lowest effective dose and titrate based on response
- 2Monitor serum sodium levels regularly during initiation
- 3Fluid restriction may be necessary to prevent hyponatremia
- 4Sublingual tablets provide more consistent absorption than nasal spray
Reconstitution Guide
Standard Reconstitution
Vial Size
4 mg
Bacteriostatic Water
1 mL
Concentration
40 mcg
per 0.1 mL (10 units)
Step-by-Step Guide
Gather Materials
Desmopressin vial, bacteriostatic water, alcohol swabs, insulin syringes.
Equilibrate Temperature
Remove the vial from storage and allow it to reach room temperature (5-10 minutes).
Sanitize
Swab the rubber stopper of both the peptide vial and bacteriostatic water vial with alcohol.
Draw Water
Draw 1 mL of bacteriostatic water into a syringe.
Add Water to Vial
Insert the needle into the peptide vial and direct the water stream against the glass wall — not directly onto the powder.
Mix Gently
Swirl the vial gently until the powder is fully dissolved. Never shake. The solution should be clear and colorless.
Store Properly
Refrigerate at 2-8°C. 24 months unopened, 48 hours after reconstitution.
Storage Temperature
2-8°C
Shelf Life
24 months unopened, 48 hours after reconstitution
Important Notes
- •Injectable formulation ready-to-use, no reconstitution needed
- •Nasal spray requires gentle priming before first use
- •Protect from light and extreme temperatures
- •Single-use vials should be discarded after opening
Desmopressin Dosing Calculator
Calculate daily intake, cycle totals, and vials needed with pre-filled protocols →
Desmopressin Reconstitution Calculator
Calculate concentration, syringe units, and doses per vial with auto-filled values →
Safety & Side Effects
Reported Side Effects
- !Hyponatremia (water intoxication)
- !Headache
- !Nausea and vomiting
- !Nasal congestion and irritation
- !Flushing
- !Abdominal cramps
- !Vulval pain (in women)
- !Injection site reactions
- !Dizziness
- !Fatigue
Potential Interactions
- ⚡Carbamazepine, chlorpropamide, NSAIDs - increase hyponatremia risk
- ⚡Lithium - may reduce antidiuretic effect
- ⚡Tricyclic antidepressants - enhance antidiuretic action
- ⚡Loop diuretics - may antagonize effects
- ⚡Corticosteroids - may increase fluid retention risk
Important: Side effects and interactions listed here are compiled from published research and community reports. This is not a complete list. No formal drug interaction studies have been conducted for most research peptides. Always consult a qualified healthcare provider.
Research Studies
The following studies are referenced in this profile. PubMed IDs are provided where available for independent verification.
Efficacy and safety of desmopressin in nocturnal enuresis
Systematic review of 47 trials showing desmopressin reduces wet nights during treatment but relapse rates are high after discontinuation.
Desmopressin for treatment of nocturia: a systematic review and meta-analysis
Meta-analysis demonstrating significant reduction in nocturnal voids and improved quality of life in adults with nocturia.
DDAVP in hemophilia A: a double-blind, controlled, crossover study
Landmark study establishing desmopressin's efficacy in raising factor VIII levels in mild hemophilia A patients.
Long-term safety of desmopressin in central diabetes insipidus
Comprehensive review of long-term desmopressin therapy showing excellent safety profile with appropriate monitoring.
Note: This is not an exhaustive list of all published research. Studies are selected for relevance and quality. Click PubMed IDs to verify sources independently. Inclusion does not imply endorsement of the peptide for any clinical use.
Frequently Asked Questions
Desmopressin is a synthetic analog of vasopressin with structural modifications that make it longer-acting and more selective for V2 receptors. Unlike natural vasopressin, desmopressin has minimal vasoconstrictive effects and lasts 8-12 hours versus 10-20 minutes for vasopressin.
Desmopressin begins working within 15-30 minutes when given by injection, and 30-60 minutes when taken intranasally or sublingually. Peak effects occur at 1-4 hours depending on the route of administration.
Yes, hyponatremia is the most serious side effect of desmopressin, especially with excessive fluid intake. Regular sodium monitoring is essential, and patients should follow fluid restriction guidelines provided by their healthcare provider.
Desmopressin is generally safe for long-term use when properly monitored. Regular assessment of sodium levels, kidney function, and clinical response is necessary to ensure continued safety and efficacy.
Take the missed dose as soon as you remember, unless it's almost time for the next dose. Never double the dose. For diabetes insipidus, missing doses can lead to increased urination and thirst, so maintaining consistent dosing is important.
Yes, desmopressin is approved for nocturnal enuresis in children over 5 years old. However, careful monitoring for hyponatremia is crucial in pediatric patients, and fluid restriction before bedtime is typically recommended.
Desmopressin can interact with several medications including NSAIDs, certain antidepressants, and diuretics. These interactions may increase the risk of hyponatremia or alter the effectiveness of desmopressin.
Store desmopressin in the refrigerator at 2-8°C (36-46°F). Nasal sprays can be stored at room temperature for up to 3 weeks after opening. Protect from light and never freeze the medication.
Research & Educational Use Only
All content is for informational and research purposes only. This site does not provide medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before using any peptide or supplement.
The information presented here is compiled from published research studies and is intended for informational purposes only. Individual results may vary. Always consult with a licensed healthcare provider.